Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

Flash-Debate: Which Oral P2Y12 Inhibitor in ACS Treated With PCI? - Clopidogrel for Most!

Presentation TCT 2020

Clopidogrel for Most!

Presenter: John Bittl

October 15, 2020

Clopidogrel vs Ticagrelor or Prasugrel in Patients70 Years or Older With NTSE ACS: POPular Age

Presentation

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

April 27, 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presentation ACC 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presenter: William Hiatt

March 29, 2020

Ticagrelor vs Clopidogrel in Patients With ACS Undergoing PCI

Presentation

Ticagrelor vs Clopidogrel in Patients With ACS Undergoing PCI

January 15, 2020

Tratamiento antiagregante en el SCA Resultados del Estudio ISAR REACT 5

Presentation CACI 2019

Tratamiento antiagregante en el SCA Resultados del Estudio ISAR REACT 5

Presenter: Carlos Fernandez Pereira

November 29, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.